cannabis indica

Ácido Tetraidrocanabinólico (THC-a)

termo de indexação original: Tetrahydrocannabinolic Acid (THC-a)

O que é Ácido Tetraidrocanabinólico (THC-a)

O ácido tetraidrocanabinólico, ou THC-a, é a forma em que o THC de fato existe na planta viva. É a molécula que a cannabis sintetiza; o THC propriamente dito é produto de sua transformação.

A diferença é um grupo carboxila, e ela muda tudo: o THC-a não é psicoativo, porque a molécula com o grupo ácido não se encaixa bem no receptor CB1. Basta aquecer — fumar, vaporizar, cozinhar, ou apenas o tempo em temperatura ambiente — para que esse grupo se desprenda como CO₂, num processo chamado descarboxilação, e o THC-a vire THC.

É por isso que cannabis crua não produz os efeitos da cannabis aquecida, e por que preparações com planta fresca são estudadas separadamente. O THC-a tem perfil farmacológico próprio, atuando em alvos como PPAR-γ e enzimas COX.

No acervo

O acervo do Cannabis Indica reúne 68 estudos científicos que tocam o composto Ácido Tetraidrocanabinólico (THC-a), publicados entre 2006 e 2023. Pela leitura automatizada, 43 (63%) foram classificados como favoráveis, 17 (25%) como inconclusivos e 8 (12%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo laboratorial (28 estudos), seguido de metanálise (22). As condições mais associadas são Câncer, Inflamação e Dor.

Estudos indexados
68
Período coberto
2006–2023
Favoráveis
43 · 63%
Inconclusivos
17 · 25%
Desfavoráveis
8 · 12%
Termo original
Tetrahydrocannabinolic Acid (THC-a)

O acervo em números

Tipo de estudo

Estudo Laboratorial28
Metanálise22
Estudo em Animais13
Ensaio Clínico4
Ensaio Clínico Duplo-Cego1

Direção do resultado

Favorável43
Inconclusivo17
Desfavorável8

Por década

2000s2
2010s18
2020s48

68 estudos

Filtrar e buscar no acervo →
  1. 2023

    An electrochemical approach for the prediction of Δ9-tetrahydrocannabinolic acid and total cannabinoid content in Cannabis sativa L

    InconclusivoEstudo Laboratorial
  2. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  3. 2023

    COMPARING DEHULLED HEMP MEAL AND CANOLA MEAL AS A PROTEIN SUPPLEMENT FOR LACTATING DAIRY COWS

  4. 2023

    Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

    FavorávelMetanáliseCâncerInflamaçãoAnsiedadeCanabigerol (CBG)Canabinol (CBN)+20
  5. 2023

    Quality and safety of hemp meal as a protein supplement for nonlactating dairy cows

    FavorávelEstudo em AnimaisAplicações VeterináriasÁcido Canabidiólico (CBD-a)Dieta
  6. 2023

    The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model

    FavorávelEstudo em AnimaisDoença de AlzheimerÁcido Canabidiólico (CBD-a)
  7. 2022

    Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services

  8. 2022

    Assessment of Delta-9-Tetrahydrocannabinol (THC) in Saliva and Blood After Oral Administration of Medical Cannabis With Respect to its Effect on Driving Abilities

  9. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  10. 2022

    Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

  11. 2022

    Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology

  12. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+28
  13. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  14. 2022

    Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

    FavorávelEstudo LaboratorialCâncerEpilepsiaDoença de ParkinsonCanabigerol (CBG)Canabinol (CBN)+4
  15. 2022

    Evaluation of the Possible Anticonvulsant Effect of Δ 9-Tetrahydrocannabinolic Acid in Murine Seizure Models

    InconclusivoEstudo em AnimaisEpilepsia
  16. 2022

    Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+3
  17. 2022

    Modulation of Recombinant Human T-Type Calcium Channels by Δ 9-Tetrahydrocannabinolic Acid In Vitro

    FavorávelEstudo LaboratorialDorEpilepsiaDoenças Neurodegenerativas
  18. 2022

    Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules

    InconclusivoEstudo em AnimaisDorPalmitoiletanolamida (PEA)Canabinol (CBN)
  19. 2022

    Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review

    InconclusivoMetanáliseCanabigerol (CBG)Canabinol (CBN)+2
  20. 2022

    Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+8
  21. 2022

    Regulating for Safety: Cannabidiol Dose in Food: A Review

    DesfavorávelMetanáliseCanabigerol (CBG)Canabinol (CBN)+5
  22. 2022

    Sex differences in medical cannabis-related adverse effects

  23. 2022

    Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+1
  24. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  25. 2022

    Time Trends of Tetrahydrocannabinol (THC) in a 2008-2021 German National Survey of Hemp Food Products

    DesfavorávelEstudo LaboratorialEfeitos Adversos da Cannabis
  26. 2021

    Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath

    FavorávelEnsaio Clínico Duplo-CegoCanabigerol (CBG)Canabinol (CBN)+1
  27. 2021

    Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress

  28. 2021

    Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+17
  29. 2021

    Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings

    DesfavorávelMetanáliseDependência QuímicaDependência — Cannabis
  30. 2021

    CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action

    FavorávelEstudo LaboratorialEstresse OxidativoCanabigerol (CBG)Canabinol (CBN)+2
  31. 2021

    Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study

    FavorávelEnsaio ClínicoCanabigerol (CBG)Canabinol (CBN)+7
  32. 2021

    Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+7
  33. 2021

    Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis

  34. 2021

    Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+2
  35. 2021

    Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

    InconclusivoEstudo LaboratorialCOVID-19Canabigerol (CBG)Canabinol (CBN)+1
  36. 2021

    Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses

    FavorávelMetanáliseCanabigerol (CBG)Canabinol (CBN)+3
  37. 2021

    Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

  38. 2021

    Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

  39. 2021

    Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+3
  40. 2021

    Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels

    DesfavorávelEstudo LaboratorialAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  41. 2021

    The antimicrobial effect behind Cannabis sativa

    FavorávelMetanáliseInfecções BacterianasAnandamida (AEA)Canabigerol (CBG)+5
  42. 2021

    Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice

    FavorávelEstudo em AnimaisInflamaçãoFibroseFibrose — Hepática (Cirrose)
  43. 2020

    A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines

    FavorávelEnsaio ClínicoDorInflamaçãoCicatrização+3
  44. 2020

    Cannabinoids and Cannabinoid Receptors: The Story so Far

    InconclusivoMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  45. 2020

    Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

  46. 2020

    In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+3
  47. 2020

    Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles

    FavorávelEstudo em AnimaisAplicações VeterináriasÁcido Canabidiólico (CBD-a)
  48. 2020

    The Influence of Hemp Extract in Combination with Ginger on the Metabolic Activity of Metastatic Cells and Microorganisms

  49. 2019

    Future Aspects for Cannabinoids in Breast Cancer Therapy

  50. 2019

    Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case Report

    FavorávelMetanáliseParalisia CerebralÁcido Canabidiólico (CBD-a)
  51. 2019

    Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients

    InconclusivoMetanáliseEpilepsiaTetraidrocanabinol (THC)Canabigerol (CBG)+5
  52. 2019

    Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity

    FavorávelEstudo em AnimaisSíndrome Metabólica
  53. 2018

    Cannabis Therapeutics and the Future of Neurology

  54. 2018

    Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression

    FavorávelEstudo LaboratorialCâncerCâncer — CólonTetraidrocanabinol (THC)Canabigerol (CBG)+2
  55. 2018

    Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

  56. 2017

    Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two

    InconclusivoEstudo Laboratorial
  57. 2017

    Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.

    FavorávelEstudo LaboratorialDII — Doença Inflamatória IntestinalDII — Doença de Crohn
  58. 2017

    Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

  59. 2016

    Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting.

  60. 2016

    High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis.

    FavorávelMetanáliseVerminosesTetraidrocanabinol (THC)
  61. 2013

    Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

  62. 2013

    Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms

    FavorávelEstudo em AnimaisCâncerCâncer — PróstataCanabigerol (CBG)Canabinol (CBN)+4
  63. 2013

    Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

  64. 2012

    Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças Neurodegenerativas
  65. 2011

    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

  66. 2011

    Evaluation Of The Cyclooxygenase Inhibiting Effects Of Six Major Cannabinoids Isolated From Cannabis Sativa

    FavorávelEstudo LaboratorialCâncerCâncer — CólonTetraidrocanabinol (THC)Canabigerol (CBG)+2
  67. 2007

    Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol

  68. 2006

    Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways

    FavorávelEstudo Laboratorial

Continue por aqui

Perguntas frequentes

Quantos estudos sobre ácido tetraidrocanabinólico (thc-a) estão indexados no acervo?
São 68 estudos, publicados entre 2006 e 2023. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Estudo Laboratorial: 28 · Metanálise: 22 · Estudo em Animais: 13 · Ensaio Clínico: 4 · Ensaio Clínico Duplo-Cego: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 43 favoráveis, 17 inconclusivos e 8 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Ácido Tetraidrocanabinólico (THC-a) — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/acido-tetraidrocanabinolico-thc-a/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Ácido Tetraidrocanabinólico (THC-a) — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/acido-tetraidrocanabinolico-thc-a/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.